Executive Director, Payer Strategy and Engagement (Tumor HI Program)

Overview Rezolute is a late-stage rare disease biopharmaceutical company focused on developing transformative therapies for patients living with severe metabolic and endocrine disorders. Our mission is to bring hope and meaningful solutions to patients and families affected by rare and difficult-to-treat diseases through scientific innovation, collaboration, and integrity. Rezolute’s lead investigational therapy, RZ358 (ersodetug), is a fully human monoclonal antibody in late-stage clinical development for the treatment of hypoglycemia due to congenital and acquired forms of hyperinsulinism (HI). As Rezolute expands its medical and scientific focus into tumor-related hyperinsulinism (tumor HI) , most commonly related to pancreatic neuroendocrine tumors (insulinomas) or paraneoplastic hypoglycemia (NICTH), the company is committed to advancing novel therapeutic strategies that address this rare and complex form of hypoglycemia associated with insulin-secreting tumors and related neuro-oncology disorders. Responsibilities Provide critical leadership and above-country market access strategies including core disease models, value stories, global pricing, economic modeling, and input into Clinical Development programs. Work closely with Medical Affairs colleagues, organized customers and distribution providers to identify real-world and patient quality of life data capture / evidence value solutions and publication opportunities. Monitor healthcare legislative trends, understand healthcare policies, assess implications of policies, and develop reimbursement strategies that address barriers to provider and patient access. Understand total cost of care and all aspects of reimbursement (coverage, coding, and payment) for outpatient and inpatient settings across multiple payer segments. Support the formulation of a clear and compelling disease and product value propositions through the creation of payer engagement (AMCP Dossier, Value and Economic Prop.), and provider / patient reimbursement support tools. Monitor the competition to understand how the evolving market will impact current and future market access strategies. Identify and develop pricing recommendations, coding and reimbursement strategies for current and pipeline assets that will support future Pricing and Reimbursement decisions in the US and other key Ex-US markets. Engage to support the advancement of ICD-10 CM coding initiatives, and product-specific HCPCS coding application. Identify product market access risks and opportunities, incorporate them into pipeline product strategies and reflect them in identified Target Product Profiles. Identify pricing and reimbursement analogues to support value and access decisions. Create payer materials for branded and unbranded disease awareness campaigns. Support the identification, creation of defensible, performance driven, quality / outcomes or risked based product / portfolio contract, or rebate opportunities. Manage agency relationships and contracts to deliver tools/tactics/resources, and ensure on time delivery, that is aligned with the departmental budget. Provide subject matter expertise to the broader organization, including competitive and product coverage access intelligence, healthcare reform, landscape trends, and pull-through initiatives. This includes cross-functional support of corp. training initiatives, content, tools and presentation development in partnership with Training and Cross-Departmental leaders. Represent Rezolute at Key Industry Conferences (e.g. AMCP, PCMA, ISPOR, Asembia, etc.). Ensure that all activities and interactions are carried out with the highest ethical and professional standards, and that all work is accomplished with quality and in accordance with Rezolute values. Manage/recruit in-house or contracted payer account team to educate key payers using PIE (Payer Information Exchange) before approval and PVP (Payer Value Proposal) after the approval Educate payers on the label and influence them to develop policies based on the label and/or clinical trial exclusion criteria Resolve rejection/prior authorization issues by closely working with the payers and patients support services team and hub in a timely manner Qualifications Experience with rare/orphan drugs is required. Therapeutic area experience is a plus. Product launch experience is required, and company start-up experience is preferred. Familiarity with current legal and regulatory landscape pertinent to the pharmaceutical/biotechnology industry. Strong analytical capabilities, with working knowledge of government pricing practices (calculations methodologies, HTA, healthcare programs, and supporting regulations), and trade systems and processes. Demonstrated flexibility to adapt to a changing environment, implement creative solutions to complex problems, and ability to function in a project leadership role. Ability to develop and maintain strong internal and external relationships, including direct collaboration with vendors and other third parties. Superior interpersonal, oral and written communication, and presentation skills, with great attention to detail. Leads with strong business acumen and a compliance mindset. Passionate about patients and building a new commercial organization. Advanced Microsoft Excel, Word and PowerPoint skills. Preferred Experience, Education, Certifications, Licenses Minimum Bachelor’s degree required; sciences or business preferred, advanced degree related medical, health economics, health outcomes research, or epidemiology (MS, MBA, MPH, MD/DO, PhD, PharmD) preferred. Minimum of 10 years of overall industry experience in biotech or pharmaceuticals (i.e. market access and reimbursement, sales, sales management, marketing, training, sales operations, or healthcare / life sciences consulting). 5 years of US market access and reimbursement experience required, with Global and/or international experience preferred. This includes, HTA, US Payer, Patient and Provider access, HEOR, and medical benefit reimbursement coding expertise. Rezolute (RZLT) currently anticipates the base salary for the Executive Director, Payer Strategy and Engagement role could range from $290,000 to $320,000 and will depend, in part, on the successful candidate’s geographical location and their qualifications for the role, including education and experience. This position will also be eligible for an annual performance bonus in accordance with the terms of the applicable plan (depending, in part, on company and individual performance and at the Company’s discretion on an individual basis). The compensation described above is subject to change and could be higher or lower than the range described based on current market survey data and the qualifications, education, experience and geographical location of the selected candidate. This role is based in the home office and requires minimum of 3 days per week in the office. Benefits and Equal Opportunity Qualifying employees are eligible to participate in benefit programs such as: Health Insurance (Medical / Dental / Vision) Disability, Life & Long-Term Care Insurance Holiday Pay Tracking Free Vacation Program 401(k) Plan Match Educational Assistance Benefit Fitness Center Reimbursement We are an Equal Opportunity Employer and do not discriminate against applicants due to race, ethnicity, gender, veteran status, or on the basis of disability or any other federal, state or local protected class. We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us. #J-18808-Ljbffr